Work for Allena Pharmaceuticals, Inc.?

Claim Your Profile

Allena Pharmaceuticals, Inc. Logo Image

Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc. Banner Image

About Allena Pharmaceuticals, Inc.

11-50 Employees
Based in Newton, Massachusetts

Allena Pharmaceuticals, Inc. is a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena’s lead product candidate, reloxaliase, is a first in class, oral enzyme therapeutic for the treatment of hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders.

NASDAQ (See More NASDAQ Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol